{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:03:31Z","timestamp":1789967011816,"version":"4.0.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the prognostic value of systolic blood pressure (SBP) time in target range (TTR) in patients with hypertension following coronary artery bypass grafting (CABG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective analysis on patients with hypertension who underwent CABG between January 2022 and May 2024 A total of 528 patients with hypertension after CABG were included in this retrospective analysis. SBP target range was de\ufb01ned as &amp;lt;140\u2005mmHg. The outcome was the occurrence within 1 year of a major adverse cardiac or cerebrovascular event, defined as death from any cause, myocardial infarction, stroke, or repeat revascularization. We used Cox proportional hazards regression models to assess the association of SBP-TTR and clinical outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 528 patients with hypertension after CABG were included in this\n                      <jats:italic>post hoc<\/jats:italic>\n                      analysis. After multivariable adjustment, a 10% increase in SBP-TTR was associated with 22% decreased risk of adverse events [hazard ratio, 0.78 (95% CI, 0.67\u20130.90);\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.001]. Compared to those with a lower SBP-TTR, patients with SBP-TTR\u2009&amp;gt;\u200975%\u2013100% were characterized by younger age, lower baseline BP, superior rate of DBP goal attainment and medication adherence. Kaplan\u2013Meier curves demonstrated that higher SBP-TTR was associated with a significantly lower event probability over time (Log-rank\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>For hypertensive patients undergoing CABG, a higher SBP-TTR is associated with an improved clinical prognosis. Efforts to enhance medication adherence represent a promising strategy to increase target achievement.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1869459","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:29:04Z","timestamp":1789964944000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic implication of time in target range of systolic blood pressure in patients with hypertension after coronary artery bypass grafting"],"prefix":"10.3389","volume":"13","author":[{"given":"Yue","family":"Song","sequence":"first","affiliation":[{"name":"Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1001\/jama.2022.0358","article-title":"Diagnosis and treatment of acute coronary syndromes: a review","volume":"327","author":"Bhatt","year":"2022","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jacc.2018.11.053","article-title":"PCI and CABG for treating stable coronary artery disease: JACC review topic of the week","volume":"73","author":"Doenst","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1136\/heart.89.7.767","article-title":"Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis","volume":"89","author":"Nalysnyk","year":"2003","journal-title":"Heart"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/j.jtcvs.2023.09.021","article-title":"Heterogeneous treatment effects of coronary artery bypass grafting in ischemic cardiomyopathy: a machine learning causal forest analysis","volume":"168","author":"Zhou","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezad136","article-title":"Evolution, coronary artery bypass surgery and outcomes of right ventricular dysfunction in ischaemic cardiomyopathy","volume":"63","author":"Zhou","year":"2023","journal-title":"Eur J Cardiothorac Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"106212","DOI":"10.1016\/j.ijsu.2021.106212","article-title":"Randomized evidence on graft patency after off-pump versus on-pump coronary artery bypass grafting: an updated meta-analysis","volume":"98","author":"Zhou","year":"2022","journal-title":"Int J Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.athoracsur.2021.12.063","article-title":"Long-term outcomes after on-pump vs off-pump coronary artery bypass grafting for ischemic cardiomyopathy","volume":"115","author":"Zhou","year":"2023","journal-title":"Ann Thorac Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/jamasurg.2018.3233","article-title":"Systolic and diastolic blood pressure variability as risk factors for adverse events after coronary artery bypass grafting","volume":"154","author":"Dyke","year":"2019","journal-title":"JAMA Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ahj.2022.12.011","article-title":"Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy","volume":"258","author":"Fu","year":"2023","journal-title":"Am Heart J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jogc.2023.02.016","article-title":"Identifying targets to improve the management of severe hypertension in pregnancy and postpartum","volume":"45","author":"Trahan","year":"2023","journal-title":"J Obstet Gynaecol Can"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1161\/HYPERTENSIONAHA.123.21651","article-title":"Systolic blood pressure time in target range and incident atrial fibrillation in patients with hypertension: insights from the SPRINT trial","volume":"80","author":"Wang","year":"2023","journal-title":"Hypertension"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e023558","DOI":"10.1161\/JAHA.121.023558","article-title":"Perioperative cardiometabolic targets and coronary artery bypass surgery mortality in patients with diabetes","volume":"11","author":"Skendelas","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26599\/1671-5411.2025.01.008","article-title":"Chinese guidelines for the prevention and treatment of hypertension (2024 revision)","volume":"22","author":"Wang","year":"2025","journal-title":"J Geriatr Cardiol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb Haemost"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jacc.2021.01.014","article-title":"Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension","volume":"77","author":"Fatani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/bmj.303.6799.385","article-title":"Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the framingham study","volume":"303","author":"D'Agostino","year":"1991","journal-title":"Br Med J"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1161\/01.cir.92.9.2437","article-title":"Blood pressure and mortality among men with prior myocardial infarction. Multiple risk factor intervention trial research group","volume":"92","author":"Flack","year":"1995","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.jacc.2014.06.009","article-title":"A polypill strategy to improve global secondary cardiovascular prevention: from concept to reality","volume":"64","author":"Castellano","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08037051.2016.1096564","article-title":"The J-curve phenomenon revisited again: sPRINT outcomes favor target systolic blood pressure below 120\u2005mmhg","volume":"25","author":"Kjeldsen","year":"2016","journal-title":"Blood Press"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1093\/eurheartj\/ehy438","article-title":"The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial","volume":"39","author":"Andersson","year":"2018","journal-title":"Eur Heart J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.jacc.2025.01.028","article-title":"Guideline-directed medical therapy and outcomes in the ISCHEMIA trial","volume":"85","author":"Maron","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/S0140-6736(10)60308-X","article-title":"Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension","volume":"375","author":"Rothwell","year":"2010","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"i4098","DOI":"10.1136\/bmj.i4098","article-title":"Blood pressure variability and cardiovascular disease: systematic review and meta-analysis","volume":"354","author":"Stevens","year":"2016","journal-title":"Br Med J"},{"key":"B29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S1474-4422(10)70066-1","article-title":"Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke","volume":"9","author":"Rothwell","year":"2010","journal-title":"Lancet Neurol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/jamacardio.2019.0751","article-title":"Visit-to-visit blood pressure variability, coronary atheroma progression, and clinical outcomes","volume":"4","author":"Clark","year":"2019","journal-title":"JAMA Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1097\/HJH.0000000000002489","article-title":"In-hospital day-by-day systolic blood pressure variability during rehabilitation: a marker of adverse outcome in secondary prevention after myocardial revascularization","volume":"38","author":"Lazzeroni","year":"2020","journal-title":"J Hypertens"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1016\/j.jacc.2011.10.903","article-title":"Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation","volume":"59","author":"Koskinas","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1161\/HYPERTENSIONAHA.125.25511","article-title":"Systolic blood pressure time in target range and acute kidney injury in patients with hypertension","volume":"82","author":"Chen","year":"2025","journal-title":"Hypertension"},{"key":"B34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.124.24013","article-title":"Time in target range for blood pressure and adverse health outcomes: a systematic review","volume":"82","author":"Wang","year":"2025","journal-title":"Hypertension"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/j.jacc.2022.08.802","article-title":"Cardiovascular risk reduction after renal denervation according to time in therapeutic systolic blood pressure range","volume":"80","author":"Mahfoud","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/jch.14816","article-title":"Combined effect of time in target range and variability of systolic blood pressure on cardiovascular outcomes and mortality in patients with hypertension: a prospective cohort study","volume":"26","author":"Feng","year":"2024","journal-title":"J Clin Hypertens"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","article-title":"Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study","volume":"388","author":"Vidal-Petiot","year":"2016","journal-title":"Lancet"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","article-title":"Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients","volume":"120","author":"Mazzaglia","year":"2009","journal-title":"Circulation"},{"key":"B39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1161\/CIRCULATIONAHA.112.124750","article-title":"Fluctuation: does blood pressure variability matter?","volume":"126","author":"Krakoff","year":"2012","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1093\/eurheartj\/ehz714","article-title":"Secondary prevention medications after coronary artery bypass grafting and long-term survival: a population-based longitudinal study from the SWEDEHEART registry","volume":"41","author":"Bj\u00f6rklund","year":"2020","journal-title":"Eur Heart J"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1161\/CIRCULATIONAHA.115.021183","article-title":"Coronary artery bypass graft versus percutaneous coronary intervention: meds matter: impact of adherence to medical therapy on comparative outcomes","volume":"134","author":"Kurlansky","year":"2016","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/jch.12037","article-title":"Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure","volume":"15","author":"Muntner","year":"2013","journal-title":"J Clin Hypertens"},{"key":"B43","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/jch.12165","article-title":"Medication class effects on visit-to-visit variability of blood pressure measurements: analysis of electronic health record data in the \u201creal world\u201d","volume":"15","author":"Smith","year":"2013","journal-title":"J Clin Hypertens"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1869459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T04:29:05Z","timestamp":1789964945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1869459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":43,"alternative-id":["10.3389\/fcvm.2026.1869459"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1869459","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1869459"}}